A Network of Protein Interactions Determines Polyglutamine Toxicity

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2006 Jul 13

PMID 16832049

Citations 86

Authors

Martin L Duennwald

Smitha Jagadish

Flaviano Giorgini

Paul J Muchowski

Susan Lindquist

Affiliations

Soon will be listed here.

Abstract

Several neurodegenerative diseases are associated with the toxicity of misfolded proteins. This toxicity must arise from a combination of the amino acid sequences of the misfolded proteins and their interactions with other factors in their environment. A particularly compelling example of how profoundly these intramolecular and intermolecular factors can modulate the toxicity of a misfolded protein is provided by the polyglutamine (polyQ) diseases. All of these disorders are caused by glutamine expansions in proteins that are broadly expressed, yet the nature of the proteins that harbor the glutamine expansions and the particular pathologies they produce are very different. We find, using a yeast model, that amino acid sequences that modulate polyQ toxicity in cis can also do so in trans. Furthermore, the prion conformation of the yeast protein Rnq1 and the level of expression of a suite of other glutamine-rich proteins profoundly affect polyQ toxicity. They can convert polyQ expansion proteins from toxic to benign and vice versa. Our work presents a paradigm for how a complex, dynamic interplay between intramolecular features of polyQ proteins and intermolecular factors in the cellular environment might determine the unique pathobiologies of polyQ expansion proteins.

Citing Articles

Disruption of the nascent polypeptide-associated complex leads to reduced polyglutamine aggregation and toxicity.

Dublin-Ryan L, Bhadra A, True H PLoS One. 2024; 19(8):e0303008.

PMID: 39146256 PMC: 11326622. DOI: 10.1371/journal.pone.0303008.

Pathologic polyglutamine aggregation begins with a self-poisoning polymer crystal.

Kandola T, Venkatesan S, Zhang J, Lerbakken B, Von Schulze A, Blanck J Elife. 2023; 12.

PMID: 37921648 PMC: 10624427. DOI: 10.7554/eLife.86939.

Comparative molecular dynamics simulations of pathogenic and non-pathogenic huntingtin protein monomers and dimers.

Khaled M, Strodel B, Sayyed-Ahmad A Front Mol Biosci. 2023; 10:1143353.

PMID: 37101557 PMC: 10123271. DOI: 10.3389/fmolb.2023.1143353.

The human ribosome-associated complex suppresses prion formation in yeast.

Kelly C, Ahmed Y, Elghawy O, Pachon N, Fontanese M, Kim S Proteins. 2023; 91(6):715-723.

PMID: 36604744 PMC: 10159891. DOI: 10.1002/prot.26461.

Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology.

Sprunger M, Lee K, Sohn B, Jackrel M iScience. 2022; 25(3):103900.

PMID: 35252808 PMC: 8889142. DOI: 10.1016/j.isci.2022.103900.

References

Ignatova Z, Gierasch L . Extended polyglutamine tracts cause aggregation and structural perturbation of an adjacent beta barrel protein. J Biol Chem. 2006; 281(18):12959-67. DOI: 10.1074/jbc.M511523200. View

Muchowski P, Schaffar G, Sittler A, Wanker E, Hartl F . Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci U S A. 2000; 97(14):7841-6. PMC: 16632. DOI: 10.1073/pnas.140202897. View

Zarrinpar A, Bhattacharyya R, Lim W . The structure and function of proline recognition domains. Sci STKE. 2003; 2003(179):RE8. DOI: 10.1126/stke.2003.179.re8. View

Zoghbi H, Orr H . Glutamine repeats and neurodegeneration. Annu Rev Neurosci. 2000; 23:217-47. DOI: 10.1146/annurev.neuro.23.1.217. View

Giaever G, Chu A, Ni L, Connelly C, Riles L, Veronneau S . Functional profiling of the Saccharomyces cerevisiae genome. Nature. 2002; 418(6896):387-91. DOI: 10.1038/nature00935. View

Schaffar G, Breuer P, Boteva R, Behrends C, Tzvetkov N, Strippel N . Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol Cell. 2004; 15(1):95-105. DOI: 10.1016/j.molcel.2004.06.029. View

Bhattacharyya A, Thakur A, Chellgren V, Thiagarajan G, Williams A, Chellgren B . Oligoproline effects on polyglutamine conformation and aggregation. J Mol Biol. 2005; 355(3):524-35. DOI: 10.1016/j.jmb.2005.10.053. View

Shorter J, Lindquist S . Prions as adaptive conduits of memory and inheritance. Nat Rev Genet. 2005; 6(6):435-50. DOI: 10.1038/nrg1616. View

Huh W, Falvo J, Gerke L, Carroll A, Howson R, Weissman J . Global analysis of protein localization in budding yeast. Nature. 2003; 425(6959):686-91. DOI: 10.1038/nature02026. View

10.

Soto C . Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 2001; 498(2-3):204-7. DOI: 10.1016/s0014-5793(01)02486-3. View

11.

Hughes R, Lo R, Davis C, Strand A, Neal C, Olson J . Altered transcription in yeast expressing expanded polyglutamine. Proc Natl Acad Sci U S A. 2001; 98(23):13201-6. PMC: 60848. DOI: 10.1073/pnas.191498198. View

12.

Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, Worm U . A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol Cell. 2004; 15(6):853-65. DOI: 10.1016/j.molcel.2004.09.016. View

13.

Nucifora Jr F, Sasaki M, Peters M, Huang H, Cooper J, Yamada M . Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science. 2001; 291(5512):2423-8. DOI: 10.1126/science.1056784. View

14.

Duennwald M, Jagadish S, Muchowski P, Lindquist S . Flanking sequences profoundly alter polyglutamine toxicity in yeast. Proc Natl Acad Sci U S A. 2006; 103(29):11045-50. PMC: 1544171. DOI: 10.1073/pnas.0604547103. View

15.

Zuccato C, Ciammola A, Rigamonti D, Leavitt B, Goffredo D, Conti L . Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science. 2001; 293(5529):493-8. DOI: 10.1126/science.1059581. View

16.

Dunah A, Jeong H, Griffin A, Kim Y, Standaert D, Hersch S . Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science. 2002; 296(5576):2238-43. DOI: 10.1126/science.1072613. View

17.

Giorgini F, Guidetti P, Nguyen Q, Bennett S, Muchowski P . A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. Nat Genet. 2005; 37(5):526-31. PMC: 1449881. DOI: 10.1038/ng1542. View

18.

Xia H, Mao Q, Eliason S, Harper S, Martins I, Orr H . RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med. 2004; 10(8):816-20. DOI: 10.1038/nm1076. View

19.

McCampbell A, Taylor J, Taye A, Robitschek J, Li M, Walcott J . CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet. 2000; 9(14):2197-202. DOI: 10.1093/hmg/9.14.2197. View

20.

Donaldson K, Li W, Ching K, Batalov S, Tsai C, Joazeiro C . Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc Natl Acad Sci U S A. 2003; 100(15):8892-7. PMC: 166409. DOI: 10.1073/pnas.1530212100. View